Pharma Co. Lied About CBD License To Investors, SEC Says
By Jonathan Capriel · October 3, 2022, 4:39 PM EDT
The U.S. Securities and Exchange Commission is going after a pair of pharmaceutical companies that it says lied to potential investors about having exclusive rights to a method for taking CBD...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login